Ekso Bionics Holdings Cash Flow Statement (2012-2026) | EKSO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-3.38M	-2.81M	-4.59M	-4.26M	-3.26M	-3.69M	-4.50M	-4.56M	-4.34M	-3.00M	-3.52M	-3.31M	-2.41M	-2.72M	-2.29M	-3.51M	-4.04M	-1.42M	-4.66M	-5.76M
Depreciation and Depletion (Quarter)	0.38M	0.28M	-0.22M	0.23M	0.23M	0.17M	-0.15M	0.41M
Share-based Compensation (Quarter)	0.52M	0.66M	0.79M	0.50M	0.58M	0.54M	0.93M	0.42M	0.51M	0.44M	0.48M	0.38M	0.28M	0.41M	0.31M	0.25M	0.21M	0.23M	0.78M	0.11M
Gains from Sales and Divestitures (Quarter)																0.19M	0.04M	0.05M	0.18M	0.00M
Gains from Investment Securities (Quarter)			-0.13M							0.87M							0.08M	0.12M	0.01M
Asset Writedowns and Impairment (Quarter)	0.02M		0.03M	-0.01M	0.00M	-0.00M	0.04M	0.00M	0.01M	0.01M	0.05M	-0.01M			-0.07M	0.02M			0.76M
Non-cash Items (Quarter)									0.02M	0.01M	0.25M	0.20M					0.01M	0.01M
Cash from Operations (Quarter)	-3.61M	-2.48M	-3.08M	-4.21M	-4.25M	-2.59M	-3.64M	-4.21M	-2.90M	-3.35M	-1.58M	-3.47M	-2.67M	-2.28M	-1.43M	-1.97M	-3.44M	-2.06M	-4.33M	-2.12M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
Amortizatization of Intangibles (Quarter)						0.00M				0.08M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)	0.00M	0.28M	-0.22M	0.23M	0.23M	0.17M	0.26M	0.41M	0.43M	0.42M	0.43M	0.41M	0.40M	0.41M	0.40M	0.38M	0.38M	0.37M	0.45M	0.45M
Change in Working Capital
Change in Receivables (Quarter)	0.50M	0.43M	1.61M	-1.30M	0.07M	0.18M	1.11M	0.20M	0.32M	0.83M	-0.14M	0.21M	0.81M	0.40M	0.54M	-0.90M	-2.15M	1.51M	1.10M	-2.42M
Change in Inventory (Quarter)	-0.09M	0.04M	0.58M	0.56M	0.66M	0.26M	-0.08M	0.38M	-0.09M	-0.12M	-0.39M	0.08M	-0.07M	0.07M	-0.34M	0.38M	0.50M	-0.49M	-0.11M	-0.17M
Change in Account Payables (Quarter)	-0.22M	-0.12M	1.80M	-0.17M	-0.88M	0.34M	0.60M	-0.11M	0.10M	-0.63M	-0.66M	0.03M	0.25M	-0.32M	-0.25M	0.44M	-0.56M	0.22M	-0.23M	0.68M
Change in Accured Expenses (Quarter)	-0.32M	0.23M	0.45M	-0.50M	-0.33M	0.57M	0.07M	-0.25M	0.19M	-0.46M	0.39M	-0.72M	0.04M	-0.17M	0.25M	-0.20M	-0.52M	-0.04M	-0.35M	-0.19M
Other Working Capital Changes (Quarter)	-0.43M	0.60M	-0.27M	0.30M	0.02M	-0.85M	0.03M	0.13M	0.01M	0.02M	-0.21M	-0.00M	0.06M	0.07M	-0.19M	0.00M	0.00M	0.00M	-0.19M	-0.30M
Investing Activities
Capital Expenditures (Quarter)			-0.00M			0.14M	0.05M	0.04M	0.06M	0.02M	0.04M	0.01M		0.01M	0.02M	0.01M	0.04M	0.01M	0.13M
Cash from Investing Activities (Quarter)			0.00M			-0.14M	-5.03M	-0.04M	-0.06M	-0.02M	-0.04M	-0.01M		-0.01M	-0.02M	-0.01M	-0.04M	-0.01M	-0.13M
Financing Activities
Other financing activities (Quarter)									0.00M				0.00M
Cash from Financing Activities (Quarter)											0.35M	3.66M	-0.27M	4.69M	-0.31M	3.53M	0.62M	-0.44M	2.92M	4.95M
Additional items
Exchange Rate Effect (Quarter)	0.01M	0.04M	0.04M	-0.02M	-0.02M	-0.00M	0.02M	0.01M	-0.01M		-0.02M	-0.02M	0.02M	0.00M	-0.03M	0.01M	0.06M	-0.01M	-0.02M	-0.01M
Change in Cash (Quarter)	-3.60M	-2.50M	-3.03M	-4.23M	-4.26M	-2.73M	-8.65M	-4.25M	-2.97M	-3.37M	-1.30M	0.16M	-2.91M	2.41M	-1.80M	1.56M	-2.81M	-2.52M	-1.55M	2.82M
Free Cash Flow (Quarter)	-3.61M	-2.48M	-3.07M	-4.21M	-4.25M	-2.73M	-3.70M	-4.26M	-2.96M	-3.37M	-1.63M	-3.47M	-2.67M	-2.29M	-1.45M	-1.98M	-3.48M	-2.07M	-4.46M	-2.12M
Net Cash Flow (Quarter)	-3.61M	-2.48M	-3.07M	-4.21M	-4.25M	-2.73M	-8.68M	-4.26M	-2.96M	-3.37M	-1.28M	0.18M	-2.94M	2.41M	-1.77M	1.55M	-2.87M	-2.51M	-1.54M	2.83M

Research Tools

Ekso Bionics Holdings Cash Flow Statement (2012-2026) | EKSO

Create an account

Sign In

Reset Password